LIFE TECHNOLOGIES INC
10-Q, EX-27, 2000-08-08
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: LIFE TECHNOLOGIES INC, 10-Q, EX-15, 2000-08-08
Next: STEPHENS INC, 13F-HR, 2000-08-08



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AND INCOME STATEMENT AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          67,072
<SECURITIES>                                         0
<RECEIVABLES>                                   82,853
<ALLOWANCES>                                     3,441
<INVENTORY>                                     82,922
<CURRENT-ASSETS>                               255,191
<PP&E>                                         193,172
<DEPRECIATION>                                  67,457
<TOTAL-ASSETS>                                 416,685
<CURRENT-LIABILITIES>                           63,531
<BONDS>                                          2,855
                                0
                                          0
<COMMON>                                           251
<OTHER-SE>                                     326,769
<TOTAL-LIABILITY-AND-EQUITY>                   416,685
<SALES>                                        218,907
<TOTAL-REVENUES>                               219,921
<CGS>                                          100,476
<TOTAL-COSTS>                                  100,476
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  59
<INCOME-PRETAX>                                 34,389
<INCOME-TAX>                                    12,380
<INCOME-CONTINUING>                             21,146
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    21,146
<EPS-BASIC>                                       0.84
<EPS-DILUTED>                                     0.84


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission